192 related articles for article (PubMed ID: 20666733)
1. Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats.
Ascensão A; Lumini-Oliveira J; Machado NG; Ferreira RM; Gonçalves IO; Moreira AC; Marques F; Sardão VA; Oliveira PJ; Magalhães J
Clin Sci (Lond); 2011 Jan; 120(1):37-49. PubMed ID: 20666733
[TBL] [Abstract][Full Text] [Related]
2. Acute exercise protects against doxorubicin cardiotoxicity.
Wonders KY; Hydock DS; Schneider CM; Hayward R
Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
[TBL] [Abstract][Full Text] [Related]
3. Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction.
Oliveira PJ; Wallace KB
Toxicology; 2006 Mar; 220(2-3):160-8. PubMed ID: 16427179
[TBL] [Abstract][Full Text] [Related]
4. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
Hydock DS; Lien CY; Schneider CM; Hayward R
Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
[TBL] [Abstract][Full Text] [Related]
5. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
Zhou S; Starkov A; Froberg MK; Leino RL; Wallace KB
Cancer Res; 2001 Jan; 61(2):771-7. PubMed ID: 11212281
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial permeability transition relevance for apoptotic triggering in the post-ischemic heart.
Correa F; Soto V; Zazueta C
Int J Biochem Cell Biol; 2007; 39(4):787-98. PubMed ID: 17306600
[TBL] [Abstract][Full Text] [Related]
7. [Aging-related increase of sensitivity of the mitochondrial permeability transition pore to inductors in the rat heart].
Sahach VF; Vavilova HL; Strutyns'ka NA; Rudyk OV
Fiziol Zh (1994); 2004; 50(2):49-63. PubMed ID: 15174206
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Oliveira PJ; Bjork JA; Santos MS; Leino RL; Froberg MK; Moreno AJ; Wallace KB
Toxicol Appl Pharmacol; 2004 Oct; 200(2):159-68. PubMed ID: 15476868
[TBL] [Abstract][Full Text] [Related]
9. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition.
Javadov S; Choi A; Rajapurohitam V; Zeidan A; Basnakian AG; Karmazyn M
Cardiovasc Res; 2008 Jan; 77(2):416-24. PubMed ID: 18006455
[TBL] [Abstract][Full Text] [Related]
10. [Mitochondrial permeability transition pore opening inhibition by ecdysterone in heart mitochondria of aging rats].
Sahach VF; Korkach IuP; Kotsiuruba AV; Rudyk OV; Vavilova HL
Fiziol Zh (1994); 2008; 54(4):3-10. PubMed ID: 18756768
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin increases the susceptibility of brain mitochondria to Ca(2+)-induced permeability transition and oxidative damage.
Cardoso S; Santos RX; Carvalho C; Correia S; Pereira GC; Pereira SS; Oliveira PJ; Santos MS; Proença T; Moreira PI
Free Radic Biol Med; 2008 Nov; 45(10):1395-402. PubMed ID: 18775776
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
Childs AC; Phaneuf SL; Dirks AJ; Phillips T; Leeuwenburgh C
Cancer Res; 2002 Aug; 62(16):4592-8. PubMed ID: 12183413
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest.
Oka N; Wang L; Mi W; Zhu W; Honjo O; Caldarone CA
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):123-30, 130.e1-2. PubMed ID: 18179928
[TBL] [Abstract][Full Text] [Related]
14. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
Zhou S; Heller LJ; Wallace KB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):60-7. PubMed ID: 11509027
[TBL] [Abstract][Full Text] [Related]
15. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
17. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis.
Ascensão A; Magalhães J; Soares JM; Ferreira R; Neuparth MJ; Marques F; Oliveira PJ; Duarte JA
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H722-31. PubMed ID: 15792986
[TBL] [Abstract][Full Text] [Related]
18. Caffeine enhances the calcium-dependent cardiac mitochondrial permeability transition: relevance for caffeine toxicity.
Sardão VA; Oliveira PJ; Moreno AJ
Toxicol Appl Pharmacol; 2002 Feb; 179(1):50-6. PubMed ID: 11884236
[TBL] [Abstract][Full Text] [Related]
19. Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts.
Liao XD; Wang XH; Jin HJ; Chen LY; Chen Q
Cell Res; 2004 Feb; 14(1):16-26. PubMed ID: 15040886
[TBL] [Abstract][Full Text] [Related]
20. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
